Pharma/Life Sciences: Corporate
France
13 years ranked
Provided by Dentons
Jean-Marc Grosperrin, a partner in Dentons' Paris office, is primarily involved in French and cross-border acquisitions, private equity transactions and industrial M&A transactions. Jean-Marc regularly advises major international groups as well as mid-sized companies.
Besides advising French and foreign companies on their acquisitions or divestitures in France and abroad, he also represents investment funds and managers in leveraged transactions.
Jean-Marc is Global Chair of the Life Science group and Co-head of the Europe and Paris Life Sciences groups. He also serves as a member of Dentons Europe Board.
Dentons (formerly Salans), 2004-Present
Started his career in 1998 at Willkie Farr & Gallagher, first in Paris and then in New York, where he concentrated on private equity acquisitions, mergers and restructurings issues.
Admitted to the Bar, Paris, 1998
Provided by Chambers
Jean-Marc Grosperrin boasts a leading corporate practice, advising pharmaceutical companies on commercial agreements and acquisitions.
Jean-Marc Grosperrin a une expertise reconnue en droit des sociétés, conseillant les entreprises pharmaceutiques sur des accords commerciaux et des acquisitions.
Provided by Chambers
Jean-Marc has enormous legal experience.
Jean-Marc is always responsive and gives good legal advice.
Jean-Marc is a high quality lawyer who is rigorous, reassuring, has a good sense of client service and helps to bring deals to fruition, while being accessible and without an oversized ego.
Jean-Marc est un avocat de grande qualité, rigoureux et rassurant. Il a un excellent sens du service à la clientèle et contribue à la conclusion des transactions, tout en étant accessible et sans prétention.
Jean-Marc a une vaste expérience juridique.
Jean-Marc est toujours réactif et donne de bons conseils juridiques.
2 items provided by Dentons
Chambers is the leading data and intelligence partner for the legal sector.